Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00591747 · ClinicalTrials.gov registry record · NA

Strength Training for Older Breast Cancer Survivors

A NA study, sponsored by OHSU Knight Cancer Institute.

Completed
Registry status
NA
Development phase
106
Enrollment target

NCT00591747 is a NA study that has completed, run by OHSU Knight Cancer Institute. The registered enrollment target is 106 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00591747, a NA study, has completed, sponsored by OHSU Knight Cancer Institute.

COMPLETED
Registry status
NA
Development phase
106 participants
Enrollment target

Study Summary

Women aged 50 and older are disproportionately affected by breast cancer, not only in terms of new diagnoses, but also in terms of survivorship. Approximately 85% of women who receive a first diagnosis of breast cancer are aged 50 and over, thus older women constitute the largest group of breast cancer survivors. Yet, few studies have focused on evaluating whether physical activity and exercise interventions affect long-term symptoms, physical fitness and function, and body composition of older breast cancer survivors. Due to the combined effects of breast cancer, related treatments and aging it is likely that exercise is even more beneficial for older breast cancer survivors than for younger survivors. Along with the cancer-related symptom of fatigue common to cancer survivors, older survivors face age-related declines in bone and muscle mass, muscle strength, bone health and physical function (gait and balance) that are likely exacerbated by reduced physical activity in survivorship and side effects of adjuvant cancer treatment. All women, regardless of age, are at risk for breast cancer recurrence. Recent epidemiologic evidence suggests a link between exercise and reduced risk of cancer recurrence in breast cancer survivors. Strength training is specifically suited to reverse or slow age-related declines in bone, muscle, strength and function and has shown promise to reduce cancer-related fatigue. However, no controlled trials of strength training in older breast cancer survivors have been conducted.

Interventions

  • BEHAVIORAL Resistance Exercise
  • BEHAVIORAL Flexibility Training

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2005-11
Est. Completion 2011-06
Phase NA

Sponsor

OHSU Knight Cancer Institute

211 total trials

What the Registry Record Tells You About NCT00591747

The ClinicalTrials.gov registry entry for NCT00591747 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Resistance Exercise is the first listed.

NCT00591747 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00591747 about?

NCT00591747 is a clinical study titled "Strength Training for Older Breast Cancer Survivors". Women aged 50 and older are disproportionately affected by breast cancer, not only in terms of new diagnoses, but also in terms of survivorship. Approximately 85% of women who receive a first diagnosis of breast cancer are aged 50 and over, thus older women constitute the largest group of breast can...

What is the current status of trial NCT00591747?

This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2005-11. Estimated completion is 2011-06.

What interventions are being tested in trial NCT00591747?

The interventions under investigation include: Resistance Exercise (BEHAVIORAL), Flexibility Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT00591747?

This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.